U.S. market Closed. Opens in 10 hours 6 minutes

PRDS | Pardes Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-31
RevenueN/AN/A
Cost of RevenueN/AN/A
Gross ProfitN/AN/A
Operating Expenses99.82M38.49M
Selling, General & Admin29.47M10.34M
Research & Development70.35M28.15M
Other Operating ExpensesN/AN/A
Operating Income-99.82M-38.49M
Other Expenses / Income3.18M-30.00K
Before Tax Income-96.63M-38.52M
Income Tax Expenses-3.18M30.00K
Net Income-93.45M-38.55M
Interest Expenses3.18M30.00K
Basic Shares Outstanding58.13M3.80M
Diluted Shares Outstanding58.13M3.80M
EBITDA-99.82M-38.49M
EBITDA Margin0.00%0.00%
EBIT-93.45M-38.49M
EBIT Margin0.00%0.00%
Financial Year End2022-12-312021-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙